| Aug 8 |
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
Xeris Biopharma: Q2 Earnings Snapshot
|
| Aug 8 |
Xeris Biopharma GAAP EPS of -$0.10 beats by $0.01, revenue of $48.07M beats by $2.26M
|
| Aug 8 |
Xeris Biopharma Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Xeris Pharmaceuticals Q2 2024 Earnings Preview
|
| Aug 2 |
Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline
|
| Aug 1 |
Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know
|
| Jul 25 |
Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024
|
| Jul 24 |
Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
|
| Jul 8 |
Xeris Biopharma CEO Paul Edick to retire
|
